Literature DB >> 17967456

Evidence that the C-terminal PB2-binding region of the influenza A virus PB1 protein is a discrete alpha-helical domain.

Emma L Poole1, Liz Medcalf, Debra Elton, Paul Digard.   

Abstract

The influenza A virus RNA-dependent RNA polymerase is a heterotrimer composed of PB1, PB2 and PA subunits and essential for viral replication. However, little detailed structural information is available for this important enzyme. We show by circular dichroism spectroscopy that polypeptides from the C-terminus of PB1 that are capable of binding efficiently to PB2 fold into stable alpha-helical structures. Structure prediction analysis of this region of PB1 indicates that it likely consists of a three-helical bundle. Deletion of any of the helices abrogated transcriptional function. Thus, PB1 contains a C-terminal alpha-helical PB2-binding domain that is essential for nucleotide polymerization activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17967456     DOI: 10.1016/j.febslet.2007.10.025

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  15 in total

Review 1.  Influenza A virus polymerase: structural insights into replication and host adaptation mechanisms.

Authors:  Stéphane Boivin; Stephen Cusack; Rob W H Ruigrok; Darren J Hart
Journal:  J Biol Chem       Date:  2010-06-10       Impact factor: 5.157

2.  Targeting of the influenza A virus polymerase PB1-PB2 interface indicates strain-specific assembly differences.

Authors:  Peter Reuther; Benjamin Mänz; Linda Brunotte; Martin Schwemmle; Kerstin Wunderlich
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

3.  Structure of influenza A polymerase bound to the viral RNA promoter.

Authors:  Alexander Pflug; Delphine Guilligay; Stefan Reich; Stephen Cusack
Journal:  Nature       Date:  2014-11-19       Impact factor: 49.962

4.  HMGB1 protein binds to influenza virus nucleoprotein and promotes viral replication.

Authors:  Dorothée Moisy; Sergiy V Avilov; Yves Jacob; Brid M Laoide; Xingyi Ge; Florence Baudin; Nadia Naffakh; Jean-Luc Jestin
Journal:  J Virol       Date:  2012-06-13       Impact factor: 5.103

Review 5.  Antiviral strategies against influenza virus: towards new therapeutic approaches.

Authors:  Arianna Loregian; Beatrice Mercorelli; Giulio Nannetti; Chiara Compagnin; Giorgio Palù
Journal:  Cell Mol Life Sci       Date:  2014-04-04       Impact factor: 9.261

6.  Structural insight into the essential PB1-PB2 subunit contact of the influenza virus RNA polymerase.

Authors:  Kanako Sugiyama; Eiji Obayashi; Atsushi Kawaguchi; Yukari Suzuki; Jeremy R H Tame; Kyosuke Nagata; Sam-Yong Park
Journal:  EMBO J       Date:  2009-05-21       Impact factor: 11.598

7.  Small molecule inhibitors of influenza A and B viruses that act by disrupting subunit interactions of the viral polymerase.

Authors:  Giulia Muratore; Laura Goracci; Beatrice Mercorelli; Ágnes Foeglein; Paul Digard; Gabriele Cruciani; Giorgio Palù; Arianna Loregian
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-02       Impact factor: 11.205

8.  CoESPRIT: a library-based construct screening method for identification and expression of soluble protein complexes.

Authors:  Yingfeng An; Patrick Meresse; Philippe J Mas; Darren J Hart
Journal:  PLoS One       Date:  2011-02-22       Impact factor: 3.240

9.  A complicated message: Identification of a novel PB1-related protein translated from influenza A virus segment 2 mRNA.

Authors:  Helen M Wise; Agnes Foeglein; Jiechao Sun; Rosa Maria Dalton; Sheetal Patel; Wendy Howard; Emma C Anderson; Wendy S Barclay; Paul Digard
Journal:  J Virol       Date:  2009-06-03       Impact factor: 5.103

10.  Virus Adaptation Following Experimental Infection of Chickens with a Domestic Duck Low Pathogenic Avian Influenza Isolate from the 2017 USA H7N9 Outbreak Identifies Polymorphic Mutations in Multiple Gene Segments.

Authors:  Klaudia Chrzastek; Karen Segovia; Mia Torchetti; Mary Lee Killian; Mary Pantin-Jackwood; Darrell R Kapczynski
Journal:  Viruses       Date:  2021-06-18       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.